NeuroSense Therapeutics
About
Advancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally. $NRSN
US
1 Broadway, Cambridge, Massachusetts
02142
Public Company
28
Biotechnology Research
Drug Development; ALS; MND; Lou Gehrig's Disease; CNS; Biopharmaceuticals; Neurodegenerative Diseases; Parkinson's Disease; Alzheimer's disease; Novel treatment
Top Decision Makers · 6
VP CMC
Sharon Cohen-Vered
******@***.com
Phone
(**) *** ****
Chief Technology Officer
Niva Russek- Blum
******@***.com
Phone
(**) *** ****
Office Manager
Bar Levin
Israel
******@***.com
Phone
(**) *** ****
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.